Additional Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    NYU Langone Medical Center
    New York NY. 10016
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Utah
    Salt Lake City UT. 84112
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Norton Pulmonary Specialists
    Louisville KY. 40241
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Arizona Pulmonary Specialists
    Phoenix AZ. 85012
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Summit Health
    Bend OR. 97701
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Vincent Medical Group
    Indianapolis IN. 46260
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Charleston SC. 29425
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Birmingham AL. 35209
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Baltimore MD. 21224
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Cleveland OH. 44195
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Philadelphia PA. 19140
    View Details

  • Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

    Clinical Physiology Laboratory
    Edmonton AB. T6G2R3
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Temple University
    Philadelphia PA. 19140
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Georgetown University Medical Center - Department of Rheumatology
    Washington D.C. DC. 20007
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Vanderbilt University Medical Center
    Nashville TN. 37208
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Thomas Jefferson University Hospital
    Philadelphia PA. 19107
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Oregon Health & Science University (OHSU)
    Portland OR. 97239
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Medical University of South Carolina (MUSC)
    Charleston SC. 29404
    View Details